These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14703580)

  • 21. [A method to determine hospital costs associated with nosocomial infections].
    Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing from a specialized surgical observation unit to an interdisciplinary surgical intensive care unit can reduce costs and increase the quality of treatment.
    Volkert T; Hinder F; Ellger B; Van Aken H
    Eur J Anaesthesiol; 2008 May; 25(5):382-7. PubMed ID: 18252015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methods for cost-effectiveness evaluation of intensive care].
    Heslet L; Andersen JS; Keiding H
    Ugeskr Laeger; 2007 Feb; 169(8):721-4. PubMed ID: 17313927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economic limits in intensive care. Can we still afford intensive care in the year 2000?].
    Barckow D
    Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):828-33; discussion 845. PubMed ID: 11190918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs of an outbreak of meticillin-resistant Staphylococcus aureus.
    Kanerva M; Blom M; Tuominen U; Kolho E; Anttila VJ; Vaara M; Virolainen-Julkunen A; Lyytikäinen O
    J Hosp Infect; 2007 May; 66(1):22-8. PubMed ID: 17433492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EuroSCORE predicts intensive care unit stay and costs of open heart surgery.
    Nilsson J; Algotsson L; Höglund P; Lührs C; Brandt J
    Ann Thorac Surg; 2004 Nov; 78(5):1528-34. PubMed ID: 15511424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Year in review 2007: Critical Care--intensive care unit management.
    Barbieri C; Carson SS; Amaral AC
    Crit Care; 2008; 12(5):229. PubMed ID: 18983704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to calculate the budget of an anaesthetic or intensive care department from revenues of g-DRGs].
    Schütt S; Gräbner B; Saathoff H; Martin J; Vagts DA
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Nov; 42(11):834-9. PubMed ID: 18040939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cluster of methicillin-resistant Staphylococcus aureus colonization in a small animal intensive care unit.
    Weese JS; Faires M; Rousseau J; Bersenas AM; Mathews KA
    J Am Vet Med Assoc; 2007 Nov; 231(9):1361-4. PubMed ID: 17975995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.
    Simoens S; Ophals E; Schuermans A
    J Adv Nurs; 2009 Sep; 65(9):1853-9. PubMed ID: 19694848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Who contributes to research in intensive medicine in Germany? An update].
    Boldt J; Maleck W; Koetter KP
    Dtsch Med Wochenschr; 2005 Feb; 130(5):197-202. PubMed ID: 15678386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
    Recinos G; Inaba K; Dubose J; Barmparas G; Teixeira PG; Talving P; Belzberg H; Demetriades D
    Am Surg; 2009 Nov; 75(11):1077-80. PubMed ID: 19927509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit.
    Bertolini G; Confalonieri M; Rossi C; Rossi G; Simini B; Gorini M; Corrado A; ;
    Respir Med; 2005 Jul; 99(7):894-900. PubMed ID: 15939252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bed occupancy and incidence of Methicillin-resistant Staphylococcus aureus infection in an intensive care unit.
    Howie AJ; Ridley SA
    Anaesthesia; 2008 Oct; 63(10):1070-3. PubMed ID: 18821886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid molecular detection of methicillin-resistant Staphylococcus aureus: a cost-effective tool for infection control in critical care?
    Struelens MJ; Denis O
    Crit Care; 2006; 10(2):128. PubMed ID: 16563177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.